Strategic Collaborations, Fresh Agreements, and Upcoming Conferences

Strategic Collaborations, Fresh Agreements, and Upcoming Conferences

Filed under: drug treatment programs maryland

Alfred Sandrock, M.D., Ph.D., Group Senior Vice President, Development Sciences and Chief Medical Officer, Biogen, said, "What attracted us to Quintiles was their depth and breadth of experience, which we believe will enhance the design, planning and …
Read more on PR Newswire (press release)

 

Pre-Open Stock Movers 4/28: (SUSS) (FURX) (AZN) Higher; (ATHX) (OGXI

Filed under: drug treatment programs maryland

GW Pharmaceuticals plc (Nasdaq: GWPH) 12.5% HIGHER; announced that the United States Food and Drug Administration (FDA) has granted Fast Track designation to Sativex® for the treatment of pain in patients with advanced cancer, who experience … The …
Read more on StreetInsider.com (subscription)

 

Alnylam, Collaborators to Offer New Clinical Data for Patisiran

Filed under: drug treatment programs maryland

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, and collaborators announced today new clinical data for patisiran (ALN-TTR02), an RNAi therapeutic targeting transthyretin (TTR) in development for the treatment of TTR …
Read more on Benzinga

 

Leave a Reply

Your email address will not be published. Required fields are marked *